Funding for this research was provided by:
Faculty of Medicine, University of Tartu
Received: 22 August 2017
Accepted: 1 February 2018
First Online: 20 February 2018
Ethics approval and consent to participate
: The study was approved by the Ethics Committee on Human Research of the University of Tartu. Written informed consent was obtained from all patients.
: Not applicable
: K. Syrjänen is an employee of Biohit Oyj and participated in the study within part of his assignments as the Chief Medical Director of the company. He is not a shareholder of the company. Pentti Sipponen is a shareholder and member of the Scientific Advisory Board of Biohit Oyj. The company develops and markets laboratory tests mainly for gastrointestinal diseases. All other authors have no conflict of interest to report.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.